A recent study published in *Nature Communications* by researchers from the University of York and the University of Copenhagen has finally clarified the long-standing mystery of nicotine production in tobacco plants. Despite centuries of tobacco use and various forms of nicotine consumption, the exact process of how tobacco synthesizes nicotine remained elusive. The researchers discovered that tobacco plants temporarily attach a glucose molecule to one of nicotine's precursors, facilitating the synthesis. This glucose molecule is removed after the reaction, leaving no trace in the final nicotine product. By identifying the enzymes that manage this attachment and removal, scientists have gained a comprehensive understanding of the nicotine biosynthetic pathway. This breakthrough has practical implications, particularly for related plants used in vaccine and medicine production, where nicotine contamination is an issue. The ability to potentially modify these plants at the genetic level could lead to strains that retain beneficial properties while eliminating nicotine, thereby enhancing their utility in medical applications.